X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-pediatric-functional-constipation
https://news.abbvie.com/news/press-releases/abbvie-submits-supplemental-new-drug-application-to-us-fda-to-support-new-indication-linzess-linaclotide-for-functional-constipation-in-children-and-adolescents-6-to-17-years-age.htm
https://www.businesswire.com/news/home/20210616005114/en/Ironwood-Pharmaceuticals-Announces-That-The-American-Journal-of-Gastroenterology-Publishes-Full-Results-from-Positive-LINZESS%C2%AE-linaclotide-Phase-IIIb-Trial-in-Adults-with-Irritable-Bowel-Syndrome-with-Constipation-IBS-C
https://endpts.com/ironwood-kicks-delayed-release-linzess-formulation-to-the-curb-after-trial-failure/
http://www.pmlive.com/pharma_news/allergan_keeps_linzess_generics_out_until_2029_with_teva_settlement_1323252
https://endpts.com/ardelyx-bags-its-first-fda-ok-for-ibs-setting-up-a-showdown-with-allergan-ironwood/
https://www.fiercepharma.com/pharma/so-long-otc-ironwood-allergan-s-linzess-takes-fight-to-non-prescription-gi-remedies-new-data
https://www.federalregister.gov/documents/2018/12/28/2018-28213/product-specific-guidance-for-linaclotide-draft-guidance-for-industry-availability
https://www.fiercepharma.com/pharma/3-5-years-and-no-deal-bruised-trulance-maker-synergy-desperate-for-new-funding
https://www.biospectrumasia.com/news/25/11576/astellas-announces-approval-of-linzess-tablets-in-japan.html
https://finance.yahoo.com/news/ironwood-pharmaceuticals-initiates-phase-iiib-120000562.html
https://www.businesswire.com/news/home/20180503006491/en/Ironwood-Allergan-Announce-Settlement-Aurobindo-Pharma-Resolving
https://endpts.com/under-pressure-peter-hecht-splits-ironwood-into-two-biotechs-spinning-out-an-rd-operation/
http://www.moneycontrol.com/news/business/companies/sun-pharma-to-end-patent-dispute-with-ironwood-allergan-in-us-over-constipation-drug-2484589.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-inzess-linaclotide-capsules-1515129224.pdf
https://www.fiercebiotech.com/biotech/toxicity-knocks-ardelyx-hyperkalemia-hopes-back-to-preclinic
http://www.pmlive.com/pharma_news/nice_backs_allergans_ibs_therapy_truberzi_1203953
https://www.astellas.com/en/corporate/news/detail/launch-of-linzess-tablets-025m.html
http://www.fiercebiotech.com/biotech/ironwood-s-colonic-delivery-platform-a-pipeline-within-a-pipeline-say-analysts
http://www.prnewswire.com/news-releases/us-food-and-drug-administration-approves-72-mcg-dose-of-linzess-linaclotide-for-adults-with-chronic-idiopathic-constipation-300397092.html
http://www.biospace.com/News/as-promised-allergan-unveils-single-digit-price/443124/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.fiercepharma.com/pharma/growth-pharma-allergan-misses-sales-eps-marks-one-time-blip-or-new-trend
http://www.fiercepharmamarketing.com/story/allergan-rolls-out-third-round-linzess-ads-targeting-patients-fed-otc-meds/2016-03-09
http://www.fiercepharma.com/story/actavis-wins-more-hearts-wall-street-top-4-morgan-stanley-pick/2015-05-19
Market Place
Share 
